EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Physiologically based pharmacokinetic modeling and dose adjustment of imipenem in pediatric patients with renal impairment

Chen Feng, Peng Xiao, Yuchen Qu, Kai Fan, Yueyuan Wang, Xinyun Zhang, Xiaolan Wang, Jie Pan, Yang Deng, Yunli Yu

Frontiers in Cellular and Infection Microbiology · 08.05.2026 · 16

DOI: 10.3389/fcimb.2026.1798911 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 08.05.2026. Verfasst von Chen Feng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Imipenem, Anti-Bacterial Agents, Renal Insufficiency. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To establish a physiologically based pharmacokinetic (PBPK) model of imipenem, predict its exposure in pediatric patients with different renal function, and optimize the dosing regimen.

Methods

GastroPlus™ was used to construct PBPK models for healthy adults, adults with renal impairment (RI), and children with normal renal function, validated by fold error (<2) between predicted and observed pharmacokinetic parameters. Based on the established PBPK models, the exposure of imipenem in pediatric patients with different renal function was predicted. Monte carlo simulations were used to evaluate the probability of target attainment (PTA) for optimized doses and to determine appropriate dosing regimens for pediatric patients with RI.

Results

The PBPK model could adequately predict the exposure of imipenem in different populations after single and multiple administrations (fold error <2). For 15 mg/kg doses, the AUC of imipenem in children with mild RI, moderate RI and severe RI was 1.05-fold, 1.26-fold, and 2.14-fold that of healthy children, respectively. Prolonging infusion from 30 min to 3 h significantly increased PTA. In addition, for susceptible bacteria with the minimum inhibitory concentration (MIC) < 4 mg/L, the recommended doses for pediatric patients aged ≥ 3 years with normal renal function, mild RI, moderate RI, and severe RI were 15, 15, 12, and 7 mg/kg every 6 hours, respectively, with a 3-hour infusion.

Conclusion

This PBPK model can accurately predict the exposure of imipenem in pediatric patients with renal impairment, and the optimized dosing regimen can meet the pharmacodynamic targets, providing support for the precise use of imipenem.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImipenemAnti-Bacterial AgentsRenal InsufficiencyHumansChildChild, PreschoolMicrobial Sensitivity TestsMonte Carlo MethodModels, BiologicalFemaleAdolescentInfantAdultMale

Stichwörter der Autor:innen

imipenempediatric patientsphysiologically based pharmacokinetic modelprobability of target attainmentrenal impairment

Substanzen

ImipenemAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pharmacy, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
  • College of Pharmacy, Soochow University, Suzhou, Jiangsu, China.
  • Hunan Provincial Key Laboratory of Anti-Resistance Microbial Drugs, The Third Hospital of Changsha, Changsha, Hunan, China.

Zitieren

APA

Feng, C., Xiao, P., Qu, Y., Fan, K., Wang, Y., Zhang, X., Wang, X., Pan, J., Deng, Y., & Yu, Y. (2026). Physiologically based pharmacokinetic modeling and dose adjustment of imipenem in pediatric patients with renal impairment. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1798911

Vancouver

Feng C, Xiao P, Qu Y, Fan K, Wang Y, Zhang X, et al. Physiologically based pharmacokinetic modeling and dose adjustment of imipenem in pediatric patients with renal impairment. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1798911

BibTeX
@article{Feng2026,
  author = {Feng, Chen and Xiao, Peng and Qu, Yuchen and Fan, Kai and Wang, Yueyuan and Zhang, Xinyun and Wang, Xiaolan and Pan, Jie and Deng, Yang and Yu, Yunli},
  title = {Physiologically based pharmacokinetic modeling and dose adjustment of imipenem in pediatric patients with renal impairment},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fcimb.2026.1798911}
}
Kostenlos starten →